Sarepta Therapeutics SRPT
NASDAQ SRPT
$18.85 +0.29 (+1.56%)
As of: Oct 22, 2026 · 9:50 AM EDT

Sarepta Therapeutics (SRPT) Short-Term Debt repayments (2026)

Updated

Sarepta Therapeutics' Short-Term Debt repayments came in at $175 million for Q2 2026, down 30.0% from the prior quarter.

Analysis

Sarepta Therapeutics (SRPT) Short-Term Debt repayments (2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Sarepta Therapeutics reported Short-Term Debt repayments of $425 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Eli Lilly 1,148.13 Bn 1,116.72 Bn 19.71 Bn -
2 Johnson & Johnson 630.09 Bn 548.62 Bn 17.26 Bn 6.45 Bn
3 AbbVie 498.99 Bn 472.10 Bn 12.70 Bn -
4 Merck 374.92 Bn 329.30 Bn 12.21 Bn -
5 Novartis Ag 300.99 Bn 264.98 Bn 11.24 Bn -
6 Astrazeneca 264.63 Bn 238.32 Bn 12.86 Bn -
7 Amgen 239.15 Bn 194.55 Bn 7.24 Bn -
8 Gilead Sciences 192.23 Bn 166.43 Bn 6.22 Bn -
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 Sarepta Therapeutics 1.97 Bn -1.26 Bn 251.87 Mn 175.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 175.00 Mn
Mar 31, 2026 250.00 Mn
API Access

Sarepta Therapeutics Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=SRPT&period=max&api_key=YOUR_API_KEY